Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr

Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr

By: IPP Bureau

Last updated : July 23, 2024 1:34 pm



Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024


Solara Active Pharma Sciences Limited has reported consolidated financial results for the period ended June 30, 2024.

Solara Active Pharma Sciences has posted net loss of Rs. 13.46 crores for the period ended June 30, 2024 as against net loss of Rs. 255.34 crores for the period ended March 31, 2024. The company posted net loss of Rs. 19.55 crores for the period ended June 30, 2023.

Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024 as compared to Rs. 301.13 crores during the period ended March 31, 2024. The company reported total income of Rs. 354.35 crores during the period ended June 30, 2023.

Solara Active Pharma Sciences Limited

First Published : July 23, 2024 12:00 am